Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Procter & Gamble Co

NYSE: PG · Industrial Applications and Services · 21 alerts · CIK 80424

Share price
$173.02Close, Nov 16
Market cap
$401B
Shares outstanding
2.32BLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Soap, Detergents, Cleang Preparations, Perfumes, CosmeticsSIC 2840

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Procter & Gamble Co filings on SEC EDGAR ↗

5:11 PM ET Form 4
Insider Selling

Procter & Gamble CEO-Baby and Feminine Care El Hak Hesham Abd Sells $379K of Stock

El Hak Hesham Abd, CEO-Baby and Feminine Care, sold 2,250 shares of Procter & Gamble Co at $168.47 a share, worth $379K in total on Nov 12, 2026. Shares held after the trade: 8,968 (-20.1%).

Value
$379K
Shares
2,250
Price
$168.47
Role
CEO-Baby and Feminine Care
Holding change
-20.1%
Trade date
Nov 12, 2026
11:02 AM ET Form 4
Insider Selling

Procter & Gamble CFO Andre Schulten Sells $5.18M of Stock

Andre Schulten, CFO, sold 30,677 shares of Procter & Gamble Co at $169.00 a share, worth $5.18M in total on Nov 5, 2026. Shares held after the trade: 65,618 (-31.9%).

Value
$5.18M
Shares
30,677
Price
$169.00
Role
CFO
Holding change
-31.9%
Trade date
Nov 5, 2026
11:01 AM ET Form 4
Insider Selling

Procter & Gamble CEO - Grooming de Azevedo Juliana Monteiro Santos Sells $908K of Stock

de Azevedo Juliana Monteiro Santos, CEO - Grooming, sold 5,370 shares of Procter & Gamble Co at $169.00 a share, worth $908K in total on Nov 5, 2026. Shares held after the trade: 21,361 (-20.1%).

Value
$908K
Shares
5,370
Price
$169.00
Role
CEO - Grooming
Holding change
-20.1%
Trade date
Nov 5, 2026
4:42 PM ET 8-K
Loan & Debt

Procter & Gamble Debt Financing Update

The Procter & Gamble Company closed an underwritten public offering of four tranches of Euro-denominated notes totaling €3.25 billion in aggregate principal amount. The offering includes notes maturing in 2030, 2034, 2038, and 2046 with interest rates ranging from 3.750% to 4.625%.

Term
Through Nov 2046
1:02 PM ET Form 4
Insider Selling

Procter & Gamble SVP - CAO Matthew W. Janzaruk Sells $1.55M of Stock

Matthew W. Janzaruk, SVP - CAO, sold 9,479 shares of Procter & Gamble Co at $163.00 a share, worth $1.55M in total on Nov 3, 2026. Shares held after the trade: 1,271 (-88.2%).

Value
$1.55M
Shares
9,479
Price
$163.00
Role
SVP - CAO
Holding change
-88.2%
Trade date
Nov 3, 2026
10:31 AM ET Form 4
Insider Selling

Procter & Gamble CEO- Health Care Paul Gama Sells $478K of Stock

Paul Gama, CEO- Health Care, sold 2,894 shares of Procter & Gamble Co at $165.00 a share, worth $478K in total on Oct 30, 2026. Shares held after the trade: 43,899 (-6.2%).

Value
$478K
Shares
2,894
Price
$165.00
Role
CEO- Health Care
Holding change
-6.2%
Trade date
Oct 30, 2026
10:29 AM ET Form 4
Insider Selling

Procter & Gamble Chf Rsch, Dev & Innov Officer Moses Victor Javier Aguilar Sells $3.09M of Stock

Moses Victor Javier Aguilar, Chf Rsch, Dev & Innov Officer, sold 18,812 shares of Procter & Gamble Co at $164.43 a share, worth $3.09M in total on Oct 30, 2026. Shares held after the trade: 55,243 (-25.4%).

Value
$3.09M
Shares
18,812
Price
$164.43
Role
Chf Rsch, Dev & Innov Officer
Holding change
-25.4%
Trade date
Oct 30, 2026
10:28 AM ET Form 4
Insider Selling

Procter & Gamble CEO-Fabric Home & Habitat Care Sundar G. Raman Sells $6.31M of Stock

Sundar G. Raman, CEO-Fabric Home & Habitat Care, sold 38,253 shares of Procter & Gamble Co at $165.00 a share, worth $6.31M in total on Oct 30, 2026. Shares held after the trade: 47,745 (-44.5%).

Value
$6.31M
Shares
38,253
Price
$165.00
Role
CEO-Fabric Home & Habitat Care
Holding change
-44.5%
Trade date
Oct 30, 2026
4:33 PM ET 8-K
Loan & Debt

Procter & Gamble $352M Debt Financing

The Procter & Gamble Company closed an underwritten public offering of $352.231 million in aggregate principal amount of Floating Rate Notes. The notes are due to mature on November 2, 2076, representing a long-term debt financing arrangement.

Value
$352M
Term
50 years
4:23 PM ET 8-K
Loan & Debt

Procter & Gamble $4B Debt Financing

The Procter & Gamble Company closed an underwritten public offering of four tranches of senior notes totaling $4.0 billion in aggregate principal amount. The offering includes notes maturing in 2031, 2033, 2036, and 2056 with interest rates ranging from 5.125% to 5.900%.

Value
$4B
Term
through Oct 2056
3:37 PM ET Form 4
Insider Selling

Procter & Gamble Chairman, President and CEO Shailesh Jejurikar Sells $5.71M of Stock

Shailesh Jejurikar, Chairman, President and CEO, sold 35,000 shares of Procter & Gamble Co at $163.09 a share, worth $5.71M in total on Oct 23, 2026. Shares held after the trade: 55,391 (-38.7%).

Value
$5.71M
Shares
35,000
Price
$163.09
Role
Chairman, President and CEO
Holding change
-38.7%
Trade date
Oct 23, 2026
11:43 AM ET Form 4
Insider Selling

Procter & Gamble Chief Human Resources Officer Balaji Purushothaman Sells $672K of Stock

Balaji Purushothaman, Chief Human Resources Officer, sold 4,181 shares of Procter & Gamble Co at $160.71 a share, worth $672K in total on Oct 23, 2026. Shares held after the trade: 11,296 (-27.0%).

Value
$672K
Shares
4,181
Price
$160.71
Role
Chief Human Resources Officer
Holding change
-27.0%
Trade date
Oct 23, 2026
10:01 AM ET Form 4
Insider Selling

Procter & Gamble CEO- Health Care Paul Gama Sells $698K of Stock

Paul Gama, CEO- Health Care, sold 4,331 shares of Procter & Gamble Co at $161.27 a share, worth $698K in total on Oct 23, 2026. Shares held after the trade: 46,793 (-8.5%).

Value
$698K
Shares
4,331
Price
$161.27
Role
CEO- Health Care
Holding change
-8.5%
Trade date
Oct 23, 2026
4:11 PM ET 10-Q
Financial Results

Procter & Gamble Q1 2026 Results: Net Income $4.73B, Down 0.4% YoY

Procter & Gamble reported net sales of $23.3 billion for the quarter ended September 30, 2026, a 4% increase over the prior year. Net earnings attributable to the company remained stable at $4.7 billion, with diluted earnings per share increasing slightly to $1.97. The company maintained strong cash flow from operations at $5.8 billion and returned $3.8 billion to shareholders through dividends and stock repurchases.

Key figure
Net income $4.73B · -0.4% YoY
10:31 AM ET 8-K
Financial Results

Procter & Gamble Financial Results

Procter & Gamble reported Q1 FY 2027 results with organic sales growth of 4.0%, driven by a 2.4% increase in organic volume. Core earnings per share rose 1% to $2.00, as productivity savings and topline growth helped offset increasing cost headwinds and marketing investments.

Term
Q1 2027
7:03 AM ET 8-K
Financial Results

Procter & Gamble Financial Results

Procter & Gamble reported first quarter fiscal 2027 net sales of $23.3 billion, a 4% increase driven by organic volume growth and favorable product mix. The company maintained its full-year organic sales and EPS growth guidance while updating net sales guidance to reflect the Thorne acquisition.

Term
Q1 2027

“Our solid sales, earnings and cash results in the first quarter reflect sharpened execution of our integrated strategy. While we expect there will continue to be geopolitical and economic challenges, this strong start keeps us on track to deliver within our guidance ranges for organic sales growth, core EPS growth and free cash flow productivity for the fiscal year.”

Shailesh Jejurikar, Chairman of the Board, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.